AIM To prepare oral colon-specific metronidazole microsphere delivery system. METHODS Metronidazole microspheres were prepared with Quasi-emulsion method, and the colon site-specific delivery prescription and preparat...AIM To prepare oral colon-specific metronidazole microsphere delivery system. METHODS Metronidazole microspheres were prepared with Quasi-emulsion method, and the colon site-specific delivery prescription and preparation optimized with fractional factorial design. RESULTS The drug loading of colon site-specific delivery metronidazole microspheres was (39 94±0 15)%, and release fraction 71 78% in an artificial colon solution. CONCLUSION Optimized by fractional factorial design metronidazole microspheres possess the characteristics of a colon site-specific delivery system that delivers its most part in an artificial solution.展开更多
文摘AIM To prepare oral colon-specific metronidazole microsphere delivery system. METHODS Metronidazole microspheres were prepared with Quasi-emulsion method, and the colon site-specific delivery prescription and preparation optimized with fractional factorial design. RESULTS The drug loading of colon site-specific delivery metronidazole microspheres was (39 94±0 15)%, and release fraction 71 78% in an artificial colon solution. CONCLUSION Optimized by fractional factorial design metronidazole microspheres possess the characteristics of a colon site-specific delivery system that delivers its most part in an artificial solution.
文摘将克隆自卡波霉素产生菌的4"-O-异戊酰基转移酶基因整合到螺旋霉素产生菌S trep tomy ces sp iramy ceticus F-21的染色体上,构建成一株稳定的生物工程菌W SJ-1-195,它产生的一组以4"-O-异戊酰螺旋霉素为主要成分的多组分基因工程新型抗生素命名为必特螺旋霉素。针对目前没有适合必特螺旋霉素产生菌的合成培养基,所以本文顺序通过部分因子析因设计法、最速上升实验、中心组合实验,并利用统计学软件SA S V 8对实验数据进行分析,确定了必特螺旋霉素合成培养基的组成,为以后对必特螺旋霉素生理生化特性的研究提供基础。经过优化后必特螺旋霉素的发酵效价从173μg/m l提高到1880μg/m l。